Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

One trip, two surgeries: could Same-Day cataract fix save time and money?

NCT ID NCT06737562

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares having cataract surgery on both eyes the same day versus waiting weeks between surgeries. Researchers want to see if same-day surgery is just as safe, costs less, and improves quality of life. About 242 adults in France with cataracts in both eyes will take part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
cataract surgery (procedure)
What this could lead to
If same-day surgery proves as safe and cheaper, it could reduce wait times and travel burden for patients with cataracts in both eyes.
What could go wrong
This is a mid-sized trial in France only, so results may not apply elsewhere. Same-day surgery carries a small risk of complications in both eyes at once.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 242 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Jul 2029

An estimate. End dates often move.

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age greater than or equal to 18 years * Indication for non-combined cataract surgery under local anaesthesia in both eyes * Patient scheduled for outpatient cataract surgery * Availability of a caregiver/accompanying person on the day of surgery and for the 1st day post-surgery * Resident in France * Speak and understand French * Consent to participate in the study * Affiliated or beneficiary of social security Exclusion Criteria: * Women of childbearing age * Surgery scheduled under general anesthesia or combined with other eye surgeries * Ocular tone \> 24 mm Hg in at least one eye on day of inclusion * Presence of risk factors for refractive error : Presence of keratoconus confirmed by corneal topography Extreme axial eye length (\< 21 mm or \> 27 mm) High myopia with posterior staphyloma History of corneal surgery (LASIK, surface laser, radial keratotomy) \- Presence of risk factors for endophthalmitis : Ocular, periocular or adnexal infections Immunosuppression Uncontrolled diabetes * Presence of risk factors for intraoperative complications Ocular, adnexal or anatomical abnormalities History of retinal detachment Lens dislocation or iridodonesis Black cataract or posterior polar cataract History of perforating or blunt ocular trauma * Presence of risk factors for corneal edema (e.g. Fuchs' endothelial dystrophy) * Presence of vision-related comorbidities (glaucoma, AMD, amblyopia, uveitis, etc.) * Presence of diabetes with diabetic retinopathy or macular edema * Patient unable to participate in follow-up (e.g., response to questionnaires) * Presence of cognitive disorders that could affect the smooth running of surgery or response to questionnaires

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bilateral cataract are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Chu Morvan

    RECRUITING

    Brest, France

  • Clinical Judge

    RECRUITING

    Marseille, France

  • Cochin Hospital

    NOT_YET_RECRUITING

    Paris, France

  • Fondation Ophtalmologique Adolphe de Rothschild

    RECRUITING

    Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.